1. Home
  2. BOLD vs BRLT Comparison

BOLD vs BRLT Comparison

Compare BOLD & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BRLT
  • Stock Information
  • Founded
  • BOLD 2018
  • BRLT 2005
  • Country
  • BOLD United States
  • BRLT United States
  • Employees
  • BOLD N/A
  • BRLT N/A
  • Industry
  • BOLD
  • BRLT Consumer Specialties
  • Sector
  • BOLD
  • BRLT Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • BOLD 24.4M
  • BRLT 22.4M
  • IPO Year
  • BOLD 2024
  • BRLT 2021
  • Fundamental
  • Price
  • BOLD $1.19
  • BRLT $1.55
  • Analyst Decision
  • BOLD Buy
  • BRLT Hold
  • Analyst Count
  • BOLD 3
  • BRLT 3
  • Target Price
  • BOLD $4.00
  • BRLT $1.80
  • AVG Volume (30 Days)
  • BOLD 105.5K
  • BRLT 55.4K
  • Earning Date
  • BOLD 08-11-2025
  • BRLT 08-07-2025
  • Dividend Yield
  • BOLD N/A
  • BRLT N/A
  • EPS Growth
  • BOLD N/A
  • BRLT N/A
  • EPS
  • BOLD N/A
  • BRLT N/A
  • Revenue
  • BOLD N/A
  • BRLT $418,708,000.00
  • Revenue This Year
  • BOLD N/A
  • BRLT $3.79
  • Revenue Next Year
  • BOLD N/A
  • BRLT $3.85
  • P/E Ratio
  • BOLD N/A
  • BRLT N/A
  • Revenue Growth
  • BOLD N/A
  • BRLT N/A
  • 52 Week Low
  • BOLD $1.00
  • BRLT $1.25
  • 52 Week High
  • BOLD $4.72
  • BRLT $2.68
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • BRLT 56.06
  • Support Level
  • BOLD N/A
  • BRLT $1.50
  • Resistance Level
  • BOLD N/A
  • BRLT $1.80
  • Average True Range (ATR)
  • BOLD 0.00
  • BRLT 0.11
  • MACD
  • BOLD 0.00
  • BRLT 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • BRLT 44.44

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: